The present application discloses fused bicyclic compounds, having substituents as disclosed herein. These compounds demonstrate ALK and/or FAK inhibitory activity and may be used to treat disorders or conditions characterized by aberrant ALK and/or FAK activity in mammals, including humans. The present application further provides pharmaceutical compositions comprising at least one of these compounds together with at least one pharmaceutically acceptable excipient.
本申请公开了融合的
双环化合物,具有如本文所披露的取代基。这些化合物展示了ALK和/或FAK抑制活性,并可用于治疗哺乳动物,包括人类中由异常的ALK和/或FAK活性所特征的疾病或症状。本申请还提供了包含至少一种这些化合物和至少一种药用可接受的赋形剂的药物组合物。